Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1451 to 1500 of 2522

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Developmental follow-up of children and young people born pretermNG72
Cabozantinib for previously treated advanced renal cell carcinomaTA463
Baricitinib for moderate to severe rheumatoid arthritisTA466
Urethrotech UCD for difficult or failed catheterisationMIB116
moorLDI2-BI: a laser doppler blood flow imager for burn wound assessmentHTG257
Nutrition support for adults: oral nutrition support, enteral tube feeding and parenteral nutritionCG32
VEST external stent for coronary artery bypass graftsMIB115
Low back pain and sciatica in over 16sQS155
Chronic kidney disease in adultsQS5
Transcatheter aortic valve implantation for aortic stenosisIPG586
Adalimumab and dexamethasone for treating non-infectious uveitisTA460
Roflumilast for treating chronic obstructive pulmonary diseaseTA461
Nivolumab for treating relapsed or refractory classical Hodgkin lymphomaTA462
Nasal Alar SpO2 sensor for monitoring oxygen saturation by pulse oximetryMIB113
Parkinson's disease in adultsNG71
Arctic Sun 5000 for therapeutic hypothermia after cardiac arrestMIB112
Constipation in children and young people: diagnosis and managementCG99
Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young peopleTA455
Ustekinumab for moderately to severely active Crohn's disease after previous treatmentTA456
New generation cardiac CT scanners (Aquilion ONE, Brilliance iCT, Discovery CT750 HD and Somatom Definition Flash) for cardiac imaging in people with suspected or known coronary artery disease in whom imaging is difficult with earlier generation CT scannersHTG281
Aquilion PRIME CT scanner for imaging coronary artery disease in adults in whom imaging is difficultMIB53
Somatom Definition Edge CT scanner for imaging coronary artery disease in adults in whom imaging is difficultMIB54
Ibrutinib for untreated chronic lymphocytic leukaemia without a 17p deletion or TP53 mutation (terminated appraisal)TA452
Bortezomib for treating multiple myeloma after second or subsequent relapse (terminated appraisal)TA453
Daratumumab with lenalidomide and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal)TA454
L-Dex U400 for lymphoedema after breast cancer treatmentMIB111
Air pollution: outdoor air quality and healthNG70
MultimorbidityQS153
Violent and aggressive behaviours in people with mental health problemsQS154
Liver diseaseQS152
Eliglustat for treating type 1 Gaucher diseaseHST5
Sacrocolpopexy using mesh to repair vaginal vault prolapseIPG583
Uterine suspension using mesh (including sacrohysteropexy) to repair uterine prolapseIPG584
Infracoccygeal sacropexy using mesh to repair vaginal vault prolapseIPG581
Infracoccygeal sacropexy using mesh to repair uterine prolapseIPG582
Etelcalcetide for treating secondary hyperparathyroidismTA448
Everolimus and sunitinib for treating unresectable or metastatic neuroendocrine tumours in people with progressive diseaseTA449
Blinatumomab for previously treated Philadelphia-chromosome-negative acute lymphoblastic leukaemiaTA450
Ponatinib for treating chronic myeloid leukaemia and acute lymphoblastic leukaemiaTA451
Multiple frequency bioimpedance devices to guide fluid management in people with chronic kidney disease having dialysisHTG441
RIDASCREEN tests for monitoring infliximab in inflammatory bowel diseaseMIB109
Neo Pedicle Screw System for spinal fusion surgeryMIB108
Oral health in care homesQS151
SecurAcath for securing cerebrospinal fluid cathetersMIB107
Spondyloarthritis in over 16s: diagnosis and managementNG65
Haematological cancersQS150
Bindex for investigating suspected osteoporosisMIB106
Endoscopic full thickness removal of non-lifting colonic polypsIPG580
Afatinib for treating advanced squamous non-small-cell lung cancer after platinum-based chemotherapy (terminated appraisal)TA444
Certolizumab pegol and secukinumab for treating active psoriatic arthritis after inadequate response to DMARDsTA445

Results per page

  1. 10
  2. 25
  3. 50
  4. All